OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
OnKure Therapeutics announced that senior management will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14-16, 2026, in New York. The company will host one-on-one investor meetings during the event. OnKure is advancing IND-enabling activities for next-generation PI3Kα inhibitor candidates OKI-345 and OKI-355, with IND submissions planned for the first half of 2027.